Lowering the risk of OHSS : the extended use of antagonist and Cabergoline
Lowering the risk of OHSS: the extended use of antagonist and Cabergoline We are aware that mild to moderate OHSS can occur, even with the agonist trigger. Can we further reduce discomfort and the risk of OHSS?
